FY2028 Earnings Estimate for STERIS’ Issued By Raymond James

STERIS’ (TSE:STE) – Equities research analysts at Raymond James cut their FY2028 earnings per share estimates for shares of STERIS’ in a research report issued to clients and investors on Friday, May 16th. Raymond James analyst M. Barth now anticipates that the company will post earnings of $0.62 per share for the year, down from their previous forecast of $0.66. Raymond James has a “Hold” rating on the stock.

STERIS’ Price Performance

About STERIS’

STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.